Literature DB >> 35814900

Long-term outcome of pathologic myopic foveoschisis treated with posterior scleral reinforcement followed by vitrectomy.

Yao Huang1, Yue Qi1, Wen-Bin Wei1, An-Li Duan1.   

Abstract

AIM: To report the long-term outcome of posterior scleral reinforcement (PSR) followed by vitrectomy for pathologic myopic foveoschisis (MF).
METHODS: The records of 27 patients (44 eyes) treated with posterior scleral reinforcement (PSR) followed by vitrectomy for pathologic MF were retrospectively reviewed. The best-corrected visual acuity (BCVA), refractive error, axial length, and spectral-domain optical coherence tomography findings and complications were analyzed.
RESULTS: Forty-four eyes of 27 patients were included in this study. The follow-up period was 47.98±18.23mo (24-83mo). The mean preoperative BCVA (logMAR) was 1.13±0.63, and the mean postoperative BCVA was 0.30±0.33 at the last visit. There showed a significant improvement in BCVA postoperatively (P<0.001). Postoperative BCVA in 41 eyes (93%) was improved compared with the preoperative one. Forty-two eyes (95.45%) got total resolution of the MF after surgery. The remaining two eyes (4.55%) got partial resolution of foveoschisis. The preoperative foveal thickness was 610.45±217.11 µm and the postoperative foveal thickness at the last visit was significantly reduced to 177.64±55.40 µm (P<0.001). The preoperative axial length was 29.60±1.71 mm, and the postoperative axial length was 29.74±1.81 mm at the last visit. There was no significant increase in axial length within 47.98±18.23mo of follow-up (P=0.562). There was no recurrence of foveoschisis or occurrence of full-thickness macular hole during the whole follow-up period.
CONCLUSION: For pathologic MF, PSR followed by vitrectomy is an effective procedure to improve the visual acuity and the anatomical structure of macula. It can also stabilize the axial length for a long time. International Journal of Ophthalmology Press.

Entities:  

Keywords:  myopic foveoschisis; posterior scleral reinforcement; vitrectomy

Year:  2022        PMID: 35814900      PMCID: PMC9203488          DOI: 10.18240/ijo.2022.06.16

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.645


  32 in total

Review 1.  Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN).

Authors:  Jorge Ruiz-Medrano; Javier A Montero; Ignacio Flores-Moreno; Luis Arias; Alfredo García-Layana; José M Ruiz-Moreno
Journal:  Prog Retin Eye Res       Date:  2018-11-01       Impact factor: 21.198

2.  Vitrectomy for myopic foveoschisis with internal limiting membrane peeling and no gas tamponade.

Authors:  Atsuro Uchida; Hajime Shinoda; Takashi Koto; Hiroshi Mochimaru; Norihiro Nagai; Kazuo Tsubota; Yoko Ozawa
Journal:  Retina       Date:  2014-03       Impact factor: 4.256

3.  Modified internal limiting membrane peeling technique (maculorrhexis) for myopic foveoschisis surgery.

Authors:  Chia-Ling Lee; Wen-Chuan Wu; Kuo-Jen Chen; Li-Yi Chiu; Kwou-Yeung Wu; Yo-Chen Chang
Journal:  Acta Ophthalmol       Date:  2016-06-20       Impact factor: 3.761

4.  RISK FACTORS FOR DEVELOPMENT OF MACULAR HOLE RETINAL DETACHMENT AFTER PARS PLANA VITRECTOMY FOR PATHOLOGIC MYOPIC FOVEOSCHISIS.

Authors:  Yao Huang; Weilin Huang; Danny S C Ng; Anli Duan
Journal:  Retina       Date:  2017-06       Impact factor: 4.256

5.  Long-term follow-up of vitrectomy in patients with pathologic myopic foveoschisis.

Authors:  Ting Zhang; Ying Zhu; Chun-Hui Jiang; Ge-Zhi Xu
Journal:  Int J Ophthalmol       Date:  2017-02-18       Impact factor: 1.779

6.  Recurrent myopic foveoschisis: resolution after internal limiting membrane removal.

Authors:  Renato Antunes Schiave Germano; Leandro Cabral Zacharias; Walter Yukiko Takahashi
Journal:  Arq Bras Oftalmol       Date:  2015 Jan-Feb       Impact factor: 0.872

Review 7.  Myopic Traction Maculopathy: Diagnostic and Management Strategies.

Authors:  Rino Frisina; Irene Gius; Michele Palmieri; Alessandro Finzi; Luigi Tozzi; Barbara Parolini
Journal:  Clin Ophthalmol       Date:  2020-11-02

8.  Treatment effect of posterior scleral reinforcement on controlling myopia progression: A systematic review and meta-analysis.

Authors:  Chih-An Chen; Pao-Yen Lin; Pei-Chang Wu
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

9.  Vitrectomy with or without internal limiting membrane peeling for myopic foveoschisis.

Authors:  Junmin Gui; Ling Ai; Ting Huang
Journal:  BMC Ophthalmol       Date:  2020-03-04       Impact factor: 2.209

Review 10.  Internal limiting membrane peeling and gas tamponade for myopic foveoschisis: a systematic review and meta-analysis.

Authors:  Bo Meng; Lu Zhao; Yi Yin; Hongyang Li; Xiaolei Wang; Xiufen Yang; Ran You; Jialin Wang; Youjing Zhang; Hui Wang; Ran Du; Ningli Wang; Siyan Zhan; Yanling Wang
Journal:  BMC Ophthalmol       Date:  2017-09-08       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.